Aporepair
ApoRepair is a French biotech company emerging from the National Center for Scientific Research (CNRS) that aims to improve the management of patients in the acute phase of myocardial infarction (MI). Reperfusion of the heart, essential to save the patient's life, generates adverse effects that diminish the expected benefit. Our therapeutic peptide protects the myocardium and improves the effects of reperfusion. This patented technology is based on a collaborative team effort spanning more than 15 years.
7-day free trial · no credit card
Verified contacts
3
available on Kipplo
LinkedIn employees
5
1 to 10 range
Open roles
—
no listings
Distinct roles
3
indexed titles
Tech stack
0
tools in use
Monthly traffic
—
organic / mo
Sign up free to see all 3 verified contacts at Aporepair
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
3 contacts with verified email or phone · masked until revealed.
No verified contacts on record for this company yet.
Top roles at Aporepair
3 distinct titles indexed · top 3 shown.
- 1chief executive officer
- 1ingénieur recherche développement
- 1é ()
Sign up to unlock all 3 contacts at Aporepair
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 3 verified contacts at Aporepair
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.